Four patients, diagnosed with refractory epilepsy, were treated with both continuous positive airway pressure (CPAP) and antiepileptic medication (AEM) and showed >50% reduction in seizures after 6 months-2 years follow-up. Two patients subsequently had AEM withdrawn and are seizure free and in one such patient, obstructive sleep apnoea (OSA) has remained the only operative diagnosis. This dual approach to care provided a real advantage to the management of patients with the dual diagnoses of OSA and epilepsy, which was refractory to standard AEM therapy.
INTRODUCTION
Epilepsy affects up to 2% of the population according to some studies' and between OS-l% in other research which has not corrected for confounding variables, such as false negative response rate2.
Sleep apnoea may affect a large proportion of the normal population 3, though it is much more prevalent amongst elderly people, (affecting up to 37%)"5 and it affects between O-20% of people with insomnia6. In many countries sleep apnoea is considered the precinct of respiratory physicians. It is only recently that Australia has realized that sleep apnoea management is also the precinct of neurologists, with the Federal Government providing a separate item number for neurologists who are acredited to practice also in the domain of sleep medicine (Item 12209)'. Although sleep apnoea and epilepsy are both common conditions, the use of a common approach to the management of both conditions is uncommon'.
The St Lukes EEG Telemetry and Sleep Centre was established by neurologists interested in both sleep medicine and epilepsy. There has since evolved a multidisciplinary approach. What follows is a review of patients who had both conditions and who required a dual approach to management.
METHODS
Patients with a diagnosis of uncontrolled epilepsy, in whom there was either a history suggestive of sleep apnoea or who demonstrated early onset snoring in either their standard EEG or during the provocative sleep deprived EEG, were referred for all-night diagnostic polysomnographic sleep study (DPSS).
Sleep studies were performed in an established sleep laboratory, using the computerized Biologic Sleepscan equipment.
Patients were admitted overnight and parameters of EEG, ECG, EOG, EMG, nasal/oral airflow, respiratory effort and oximetry were monitored. At all times, patients were under the supervision of a qualified sleep technician and all studies were manually score< prior to final interpretation.
Those patients with a respiratory disturbance index (RDI) of ~4 [defined as the number of respiratory events (apnoea or hypopnoea) > 10 s duration per hour and/or desaturation >5%) who had significant hypopnoea/apnoea as measured both in frequency and duration, were readmitted for continuous positive airway pressure (CPAP) all-night polysomnographic study (CPAP-PS), in which CPAP pressure was titrated to a level that would overcome apnoeic episodes.
The patients' response rate and compliance to CPAP therapy were monitored.
RESULTS

Case 1
MA, a 39-year-old man, first presented in 1990 with secondarily generalized tonic-clonic seizures, treated with combination therapy of valproate (VPA) and carbamazepine (CBZ). Over the next 5 years his antiepileptic medication (AEM) was titrated, but he still continued to have seizures at a rate of one per month. In mid-1995, an EEG showed bitemporal independent epileptic activity and he had early onset snoring while drifting off to sleep. He underwent a DPSS in September 1995. This revealed 29 episodes of hypopnoea/apnoea with a respiratory disturbance index (RDI) of 5. Mean duration of episodes was approximately 18 s with the longest episode lasting 41 s. His awake baseline oxygen saturation (SA02) was 96% and his lowest, 84%. On the basis of these findings he underwent an all-night CPAP-PS which confirmed a need for a 8-cm water CPAP, which he used routinely. Since then he has averaged one seizure per 3 months. When reviewed in August 1996, he was almost 6 months seizure free with VPA and CBZ within the therapeutic range. Case 2 JE, a 50-year-old male public servant, presented in June 1995 with what was reported to be an EEG confirmed diagnosis of epilepsy and deteriorating work performance, presumably as a consequence of seizures, for assessment for worker's compensation.
He had experienced three definite episodes diagnosed as complex partial seizures and was thought to be having numerous absences that could not be adequately quantified.
He was on VPA and vigabatrin (VGB). An EEG performed in September 1995 demonstrated non-specific slowing of the background activity with phase reversed abnormality in the right posterior temporal region but no diagnostic epileptic activity. He also demonstrated early onset snoring. Cerebral imaging was normal.
On the basis of early onset snoring, he was referred for DPSS which demonstrated 131 episodes of hypopnoea/apnoea with RDI of 19.5. Baseline awake SAOz was 96% and lowest was 84%. CPAP-PS confirmed 6 cm of water to be the optimal pressure.
Review of the history and investigations suggested that sleep apnoea was the appropriate diagnosis and the diagnosis of refractory epilepsy inappropriate.
AEM were weaned out and the obstructive sleep apnoea responded well to CPAP with improved work performance and no further episodes. Case 3 CW, a 23-year-old man, presented in 1993 following his first tonic-clonic seizure, which was associated with incontinence and tongue biting. EEG showed left focal abnormality but no features of epilepsy and cerebral CT scan revealed left frontal haemorrhage. Angiogram was normal and investigations for vasculitis were unhelpful. He represented in August 1995 after a further tonic-clonic seizure and experienced a further convulsion while in the Accident and Emergency Department. His wife reported nocturnal shaking and a history which was suggestive of sleep apnoea.
Repeat angiography and tests for vasculitis were unhelpful, but CT scanning demonstrated a further intracerebral bleed. MRI was suggestive of cavernous haemangioma. He was commenced on phenytoin and the haemangioma was confirmed and removed surgically.
Since his history suggested sleep apnoea, he underwent a DPSS which revealed 95 apnoea/hypopnoea episodes with an RDI of 12.6. Mean duration of episodes was approximately 17 s with a longest episode of 40 s. Mean waking SAO;? was 97.5% and lowest SA02 was 90%. CPAP-PS confirmed the need for 12 cm of water and he is presently 6 months seizure free. Case 4 DF, a 53-year-old man, was first seen in 1988 following what was thought to be alcohol-related complex partial seizures and secondarily generalized tonic-clonic convulsions.
Sleep deprived EEG showed right frontal abnormality but no classical epileptiform features. He was commenced on CBZ with therapeutic drug levels obtained.
He represented a year later with further convulsions, again thought to be alcohol related, and this pattern persisted with both variable compliance with AEM and abstinence from alcohol. Liver enzymes were significantly elevated and chronic hepatitis suspected. Liver biopsy was performed and showed mild inflammation, thought to relate to CBZ. He complained of excessive fatigue on CBZ and oxcarbazepine (OXC) was substituted and subsequently VPA added.
When examined in 1993, he had been abstinent from alcohol for 3 years but continued to complain of seizures plus headaches. Further history was suggestive of sleep apnoea. In October 1993, he underwent a DPSS with 140 episodes of hypopnoea/apnoea and an RDI of 17.5. Mean duration of episodes was approximately 18s and the longest duration was 144s. Baseline awake SAOz was 95.2%, with a lowest SAOz of 84%. CPAP-PS established a need for 5 cm water pressure and he continued on combination therapy with CPAP and VPA plus QXC. His seizure rate fell from approximately one seizure per 2 months to two seizures per year.
DISCUSSION
Figures for sleep apnoea prevalence vary greatly between studies3-'. Australian research found that 81% of a sample of almost 300 healthy male volunteers, aged 40-65 years, snored for more than 10% of the night and 22% for more than half the night. Twenty-six per cent had an RDI of 25 and 10% had an RDI 2 109. This study found less association between sleep apnoea than was the case in our experience in which snoring, provoked during sleep deprived and standard EEG, was often associated with obstructive sleep apnoea'".
Sleep deprivation has long been recognized as a provocative test to enhance yield of epilepsy when performing an EEG" but it has not been recognized that early onset snoring, while performing such a study, is a good indication for performing a DPSS to look for sleep apnoea".
The patients described here were all considered to have refractory epilepsy at the time of referral. Two of these patients had early onset snoring during their EEGs and JE was ultimately thought not to have epilepsy at all, but only sleep apnoea. The other two patients underwent DPSS because of a history that was suggestive of sleep apnoea.
Use of CPAP has dramatically improved seizure control for all four patients with both MA and CW becoming seizure free and DF having at least 66% reduction in seizure rate. MA and DF have remained on AEM, while JE and CW were taken off medication, though both remained under observation to ensure that they remained seizure free. These findings support similar results reported by Devinski et a?' who recognized that adequate correction of sleep deprivation, produced as a consequence of sleep apnoea, was of significant benefit in the care of seven patients who had the dual diagnoses of epilepsy and OSA.
It would appear that adequate therapy of sleep apnoea may significantly enhance seizure management in those patients who experience both epilepsy and obstructive sleep apnoea. It is important that epileptologists are acutely aware of the potential for both diagnoses of epilepsy and OSA to coexist and thereby offer suitable intervention when required.
.
